Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPL512,602 in moderate to severe persistent asthma
NCT00330070Phase 2Completed
- Sponsor
- Inflazyme Pharmaceuticals Ltd.
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IPL512,602 in asthma, sponsored by Inflazyme Pharmaceuticals Ltd.. Started May 2006; status: completed.
02
Drugs
IPL512,602
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00330070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330070.